We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.36%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.03B
AUM Growth
–
Cap. Flow
+$8.05B
Cap. Flow %
100.3%
Top 10 Hldgs %
18.06%
Holding
2,281
New
2,279
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$264M
2
JNJ icon
Johnson & Johnson
JNJ
+$229M
3
CVX icon
Chevron
CVX
+$157M
4
PG icon
Procter & Gamble
PG
+$143M
5
IBM icon
IBM
IBM
+$130M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 13.36%
2 Healthcare 12.61%
3 Industrials 12.03%
4 Financials 10.68%
5 Energy 10.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVA
901
DELISTED
Covanta Holding Corporation
CVA
$302K ﹤0.01%
+15,086
New +$302K
ADM icon
902
Archer Daniels Midland
ADM
$41.4B
$297K ﹤0.01%
+8,810
New +$294K
FRTX
903
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$296K ﹤0.01%
+30
New +$332K
MCRL
904
DELISTED
MICREL INC
MCRL
$296K ﹤0.01%
+30,000
New +$299K
SPLV icon
905
Invesco S&P 500 Low Volatility ETF
SPLV
$7.2B
$292K ﹤0.01%
+9,399
New +$296K
FINL
906
DELISTED
Finish Line
FINL
$292K ﹤0.01%
+13,403
New +$273K
VALE icon
907
Vale
VALE
$62.9B
$291K ﹤0.01%
+22,197
New +$349K
SRDX
908
DELISTED
Surmodics
SRDX
$289K ﹤0.01%
+14,456
New +$362K
BCPC
909
Balchem Corp
BCPC
$5.23B
$289K ﹤0.01%
+6,498
New +$291K
HTS
910
DELISTED
HATTERAS FINANCIAL CORP
HTS
$289K ﹤0.01%
+11,786
New +$311K
SGMO
911
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$288K ﹤0.01%
+36,986
New +$323K
STWD icon
912
Starwood Property Trust
STWD
$6.12B
$288K ﹤0.01%
+14,507
New +$310K
OA
913
DELISTED
Orbital ATK, Inc.
OA
$288K ﹤0.01%
+3,500
New +$265K
IDXX icon
914
Idexx Laboratories
IDXX
$42.9B
$287K ﹤0.01%
+6,410
New +$280K
RES icon
915
RPC Inc
RES
$1.24B
$287K ﹤0.01%
+20,860
New +$285K
FMBI
916
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$284K ﹤0.01%
+20,713
New +$266K
KBR icon
917
KBR
KBR
$4.68B
$283K ﹤0.01%
+8,750
New +$279K
PCH
918
DELISTED
PotlatchDeltic
PCH
$283K ﹤0.01%
+7,006
New +$321K
PBI icon
919
Pitney Bowes
PBI
$2.42B
$282K ﹤0.01%
+19,273
New +$285K
AAN.A
920
DELISTED
The Aaron's Company Inc Class A
AAN.A
$281K ﹤0.01%
+10,044
New +$281K
ETR icon
921
Entergy
ETR
$54.1B
$280K ﹤0.01%
+8,078
New +$278K
GHL
922
DELISTED
Greenhill & Co., Inc.
GHL
$280K ﹤0.01%
+6,138
New +$297K
FRC
923
DELISTED
First Republic Bank
FRC
$280K ﹤0.01%
+7,301
New +$279K
RWX icon
924
State Street SPDR Dow Jones International Real Estate ETF
RWX
$265M
$279K ﹤0.01%
+6,998
New +$303K
ARRS
925
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$279K ﹤0.01%
+19,501
New +$308K
35 36
37
38 39

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Glenmede Trust, which disclosed 2,281 positions worth $8.03B. Its ten largest holdings account for 18% of the portfolio.

Its largest position is ExxonMobil: 2,929,510 shares worth $265M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, followed by Healthcare and Industrials.

  • Glenmede Trust's largest Q2 2013 buy was ExxonMobil: 2,929,510 shares worth $265M.
  • Glenmede Trust's ten largest holdings make up 18% of its $8.03B portfolio in Q2 2013.
  • Glenmede Trust disclosed 2,281 positions in Q2 2013, its first 13F filing on record.

Based on Glenmede Trust's 13F filing for Q2 2013, filed 15 Aug 2013.